CIMAvax-EGF-Platelets-Adults- Lung Cancer |
03/08/2018 |
CIM |
NeuroEPO in stroke |
02/08/2018 |
CIM |
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults |
18/03/2021 |
CIM |
CIMAvax-EGF in different maintenance schemes |
12/05/2021 |
CIM |
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers |
2013-02-08 |
CIGB |
MAGINC Study |
2011-07-12 |
CIGB |
HeberproGen Study |
2011-05-20 |
CIGB |
TS-FARMEV Study |
2011-05-16 |
CIGB |
AntiCEA M3-I |
2010-12-20 |
CIGB |
CIGB-128 administration to patients with surgically-treated keloids. |
2010-12-24 |
CIGB |
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed |
2010-12-27 |
CIGB |
FASECU I |
2008-10-16 |
CIGB |
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
2009-02-11 |
CIGB |
THERESA-3 Study |
2009-12-11 |
CIGB |
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. |
2010-09-27 |
CIGB |
Interferon Combination in basal cell carcinoma (InCarbacel-IV study) |
22/08/2013 |
CIGB |
ESPERANZA study |
14/04/2020 |
CIGB |
THERESA-5 Study |
08/04/2015 |
CIGB |
CIGB 2020 in contacts and SARS-CoV-2 infection suspects |
13/04/2020 |
CIGB |
VIDA study |
22/06/2020 |
CIGB |